AE	adverse event
CPS	combined positive score
CR	complete response
DCR	disease control rate
G	grade
HD	high dose
HR	hazard ratio
ICI	immune-checkpoint inhibitors
IMDC	International Metastatic
RCC	Database Consortium
ITT	intention-to-treat
IV	intravenously
MoAb	monoclonal antibody
MSKCC	Motzer Score For Renal Cell Carcinoma
RCC	renal cell carcinoma
nccRCC	non-clear cell RCC
mRCC	metastatic RCC
ORR	objective response rate
OS	overall survival
PD	progressive disease
PD-L1	programmed death-ligand 1
PD-1	programmed death 1
PFS	progression-free survival
PR	partial response
RCC	renal cell carcinoma
RFS	recurrence-free survival
SD	stable disease
TMB	tumor mutational burden
TPS	tumor proportion score
TKI	tyrosine kinase inhibitor
tRCC	translocation RCC
VEGF	vascular endothelial growth factor
VEGF-R	vascular endothelial growth factor- receptor
WHO	World Health Organization